Yohn J, Hoffman S, Norris D, Robinson W
Division of Medical Oncology, University of Colorado School of Medicine, Denver.
Hosp Pract (Off Ed). 1994 Jul 15;29(7):27-34. doi: 10.1080/21548331.1994.11443044.
The tumors can progress rapidly from superficial lesions of the epidermis, which are nearly all curable by excision, to invasive cancers unresponsive to current therapy. New strategies for regional and systemic spread include multiagent chemotherapy combined with biologic response modifiers, such as alpha-interferon or interleukin-2. On the early evidence, some of these approaches are promising.
肿瘤可从几乎都能通过切除治愈的表皮浅表病变迅速发展为对当前治疗无反应的浸润性癌症。针对局部和全身扩散的新策略包括多药化疗联合生物反应调节剂,如α干扰素或白细胞介素-2。根据早期证据,其中一些方法很有前景。